1 – 10 of 54
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Monoclonal gammopathy of undetermined significance with multiple paraproteins : A population-based screening study
(
- Contribution to journal › Article
-
Mark
Monoclonal gammopathy of undetermined significance and the risk of thrombotic events : Results from iStopMM, a prospective population-based screening study
2024) In British Journal of Haematology(
- Contribution to journal › Article
-
Mark
Prior cancer and risk of monoclonal gammopathy of undetermined significance : a population-based study in Iceland and Sweden
(
- Contribution to journal › Article
-
Mark
Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance : An Analysis From a Population-Based Screening Study
(
- Contribution to journal › Article
-
Mark
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial
(
- Contribution to journal › Article
- 2022
-
Mark
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease : Results of the iStopMM study
(
- Contribution to journal › Article
- 2021
-
Mark
Untangling fracture risk in monoclonal gammopathy of undetermined significance : A population-based cohort study
(
- Contribution to journal › Article
-
Mark
Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma
(
- Contribution to journal › Article
-
Mark
A nationwide study on inpatient opportunistic infections in patients with chronic lymphocytic leukemia in the pre-ibrutinib era
(
- Contribution to journal › Article
-
Mark
Comorbidities in multiple myeloma and implications on survival : A population-based study
(
- Contribution to journal › Article